As of Q4'25, DDOG's latest operating expenses show R&D Expenses at USD 418M and SG&A Expenses at USD 339M, both reaching their highest levels in the reported period. This marks a continued increase in spending, with R&D leading as the largest component of total operating expenses. From Q1'23 to Q4'25, both R&D and SG&A Expenses have demonstrated a steady upward trend, with R&D Expenses rising from USD 229M to USD 418M and SG&A Expenses increasing from USD 187M to USD 339M. The growth is particularly pronounced in the last four quarters, indicating an acceleration in investment, especially in R&D, which consistently outpaces SG&A. This sustained expansion in operating expenses suggests DDOG is prioritizing growth and development initiatives over the observed period.